Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Needle Based Biopsy Gun Market, By Product Type (Disposable, Reusable), Applications (vacuum-assisted biopsy devices (VAB), core needle biopsy devices (CNB), and fine needle aspiration biopsy devices (FNAB)) – Industry Trends and Forecast to 2029
Needle Based Biopsy Gun Market Analysis and Size
The needle based biopsy gun market is expected to witness significant growth during the forecast period. The expansion of the global market for needle-based biopsy guns is directly proportional to the incidence of cancer cases worldwide. This will increase the acceptance of needle-based biopsy guns, thereby advancing the market. Rapid innovation and technological advances impact the global needle based biopsy gun market, with ongoing product development to improve patient comfort during and after surgery and reduce trauma. This market is at utmost demand and is expected to foresee a huge growth in the forecast period.
Data Bridge Market Research analyses a growth rate in the needle based biopsy gun market in the forecast period 2022-2029. The expected CAGR of global needle based biopsy gun market is tend to be around 7.0% in the mentioned forecast period. The market was valued at USD 467 million in 2021, and it would grow upto USD 802.39 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Needle-based biopsy guns are handheld devices that consists of motor assembly attached to a biopsy needle, which is used to collect tissue samples from a patient’s body to detect malignancies. These tools can be automatic, semiautomatic, or manual, with a spring-loaded mechanism that allows for a minimally invasive insertion into the skin to collect samples for additional laboratory testing. The procedure is performed using image-guidance modalities such as magnetic resonance imaging (MRI), X-ray imaging, ultrasound imaging and computed tomography (C.T.). It is gaining huge importance to physicians and doctors and is expected to have a huge growth in the forecast period.
Needle Based Biopsy Gun Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product Type (Disposable, Reusable), Applications (vacuum-assisted biopsy devices (VAB), core needle biopsy devices (CNB), and fine needle aspiration biopsy devices (FNAB)) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Cardinal Health (U.S.), Devicor Medical Products, Inc. (U.S.), BD (U.S.), Cook Group (U.S.), Leica Biosystems Nussloch GmbH (Germany), Argon Medical (U.S.), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan) |
|
Market Opportunities |
|
Global Needle Based Biopsy Gun Market Dynamics
Drivers
- Increasing Cancer Cases
Incidence of cancer cases is directly helping expand the needle based biopsy guns market globally. According to the WHO, in 2030, deaths caused because of cancer are expected to reach 13 billion worldwide. A rapid growth in incidence of cancer across the globe is expected to increase the number of patients undergoing biopsies. This will consequently increase the adoption of needle based biopsy guns thereby, driving the market growth.
- Increased Geriatric Population
Cancer is thought to be an age-related disease, according to researchers. According to studies, persons over the age of 50 are more prone to cervical, breast, and prostate cancer. During the projected period, this is expected to push the market.
Opportunities
- Clinical Research and Reimbursement
The innovation of needle biopsy, promising clinical studies, and improved reimbursement policies are projected to provide substantial growth opportunities for the needle-based biopsy gun market from 2022 to 2029.
- Advanced Technologies
Adopting technologies such as using artificial intelligence in the needle-based biopsy gun market is creating an opportunity for the growth of the same. For instance, Freenome, an A.I. genomics business based in the United States, announced in October 2018 that it is working on developing blood tests that utilize A.I. to detect the body's early-warning indications of cancer. The company released preliminary evidence in R&D in October 2018 for applying machine learning to detect colorectal cancer in its early stages.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these systems could curb the growth of the needle based biopsy gun market over a forecast period.
- High Cost
High cost of these treatment processes can hinder the growth of the needle based biopsy gun market even though the prevalence of the diseases are high.
This needle based biopsy gun market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the needle based biopsy gun market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Needle Based Biopsy Gun Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
In the post pandemic era, there is huge anticipation of surge in the global needle based biopsy gun market as cancer incidence is independent of the current scenario. And also, as the hospitals and research centers have lower cases of covid-19 infection, the focus will increase again towards the cancer cases.
Global Needle Based Biopsy Gun Market Scope
The global needle based biopsy gun market is segmented on the basis of product, application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Disposable
- Reusable
Application
- Vacuum-assisted biopsy devices (VAB)
- Core needle biopsy devices (CNB)
- Fine needle aspiration biopsy devices (FNAB)
Needle Based Biopsy Gun Market Regional Analysis/Insights
The needle based biopsy gun market is analysed and market size insights and trends are provided by product, application as referenced above.
The major countries covered in the needle based biopsy gun market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is the dominating region in the needle based biopsy gun market due to increasing cancer incidence.
Asia-Pacific region has shown significant growth in the global needle-based biopsy gun market due to increased awareness about biopsy procedures and the elderly population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Needle Based Biopsy Gun Market Share Analysis
The needle based biopsy gun market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to needle based biopsy gun market.
Key players operating in the needle based biopsy gun market include:
- Cardinal Health (U.S.)
- Devicor Medical Products, Inc. (U.S.)
- BD (U.S.)
- Cook Group (U.S.)
- Leica Biosystems Nussloch GmbH (Germany)
- Argon Medical (U.S.)
- B. Braun Melsungen AG (Germany)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (U.S.)
- FUJIFILM Holdings Corporation (Japan)
SKU-
